Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA

作者: Mancini , Simi , Salvianti , Castiglione , Sonnati

DOI: 10.3390/DIAGNOSTICS9030117

关键词:

摘要: Next Generation Sequencing (NGS) is a promising tool for the improvement of tumor molecular profiling in view identification personalized treatment oncologic patients. To verify potentiality targeted NGS (Ion AmpliSeq™ Cancer Hotspot Panel v2), selected melanoma samples (n = 21) were retrospectively analyzed on S5 platform order to compare performance with conventional techniques adopted our routine clinical setting (Sequenom MassARRAY system, Sanger sequencing, allele-specific real-time PCR). The capability rare and low-frequency mutations main genes involved (BRAF NRAS genes) was verified integrated results deriving from other oncogenes suppressor genes. analytical evaluation carried out by analysis DNA derived control cell lines FFPE (Formalin-Fixed, Paraffin-Embedded) that achieved resolution uncommon variants suitable meet technical requests. Our demonstrate amplicon-based approach can reach sensitivity proper assays together high specificity sequencing method. An overall concordance among tested methods observed classical mutations. assessment quality parameters comparison orthogonal suggest method could be implemented characterization.

参考文章(40)
Andrea Warrick, Erin M. Forbes, Dylan Nelson, Emily Justusson, Judith Levine, Tanaya L. Neff, Janice Patterson, Ajia Presnell, Arin McKinley, Laura J. Winter, Christie Dewey, Amy Harlow, Oscar Barney, Brian J. Druker, Kathryn G. Schuff, Christopher L. Corless, Carol Beadling, Michael C. Heinrich, Multiplex Mutation Screening by Mass Spectrometry: Evaluation of 820 Cases from a Personalized Cancer Medicine Registry The Journal of Molecular Diagnostics. ,vol. 13, pp. 504- 513 ,(2011) , 10.1016/J.JMOLDX.2011.04.003
Gro Vatne Røsland, Agnete Svendsen Tenfjord Engelsen, Novel points of attack for targeted cancer therapy. Basic & Clinical Pharmacology & Toxicology. ,vol. 116, pp. 9- 18 ,(2015) , 10.1111/BCPT.12313
Matthew Holderfield, Marian M. Deuker, Frank McCormick, Martin McMahon, Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond Nature Reviews Cancer. ,vol. 14, pp. 455- 467 ,(2014) , 10.1038/NRC3760
John A. Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N. Patel, Klaus J. Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E. LeBoit, Dan Pinkel, Boris C. Bastian, Distinct Sets of Genetic Alterations in Melanoma The New England Journal of Medicine. ,vol. 353, pp. 2135- 2147 ,(2005) , 10.1056/NEJMOA050092
M Ong, S Carreira, J Goodall, J Mateo, I Figueiredo, D N Rodrigues, G Perkins, G Seed, T A Yap, G Attard, J S de Bono, Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail British Journal of Cancer. ,vol. 111, pp. 828- 836 ,(2014) , 10.1038/BJC.2014.350
Christopher L. Corless, Carol Beadling, Tanaya L. Neff, Michael C. Heinrich, Katherine Rhodes, Michael Thornton, John Leamon, Mark Andersen, Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping The Journal of Molecular Diagnostics. ,vol. 15, pp. 171- 176 ,(2013) , 10.1016/J.JMOLDX.2012.09.003
Simone M. Goldinger, Carla Murer, Pascale Stieger, Reinhard Dummer, Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations Ejc Supplements. ,vol. 11, pp. 92- 96 ,(2013) , 10.1016/J.EJCSUP.2013.07.011
Umberto Malapelle, Elena Vigliar, Roberta Sgariglia, Claudio Bellevicine, Lorenzo Colarossi, Domenico Vitale, Pierlorenzo Pallante, Giancarlo Troncone, Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients Journal of Clinical Pathology. ,vol. 68, pp. 64- 68 ,(2015) , 10.1136/JCLINPATH-2014-202691
Alan E. Siroy, Genevieve M. Boland, Denái R. Milton, Jason Roszik, Silva Frankian, Jared Malke, Lauren Haydu, Victor G. Prieto, Michael Tetzlaff, Doina Ivan, Wei-Lien Wang, Carlos Torres-Cabala, Jonathan Curry, Sinchita Roy-Chowdhuri, Russell Broaddus, Asif Rashid, John Stewart, Jeffrey E. Gershenwald, Rodabe N. Amaria, Sapna P. Patel, Nicholas E. Papadopoulos, Agop Bedikian, Wen-Jen Hwu, Patrick Hwu, Adi Diab, Scott E. Woodman, Kenneth D. Aldape, Rajyalakshmi Luthra, Keyur P. Patel, Kenna R. Shaw, Gordon B. Mills, John Mendelsohn, Funda Meric-Bernstam, Kevin B. Kim, Mark J. Routbort, Alexander J. Lazar, Michael A. Davies, Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma Journal of Investigative Dermatology. ,vol. 135, pp. 508- 515 ,(2015) , 10.1038/JID.2014.366
Birgitte B. Simen, Lina Yin, Chirayu P. Goswami, Kathleen O. Davis, Renu Bajaj, Jerald Z. Gong, Stephen C. Peiper, Erica S. Johnson, Zi-Xuan Wang, Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory. Archives of Pathology & Laboratory Medicine. ,vol. 139, pp. 508- 517 ,(2015) , 10.5858/ARPA.2013-0710-OA